Introduction
Corneal cross-linking (CXL) is the only treatment proven to halt the progression of keratoconus — a progressive thinning and distortion of the cornea that causes irregular vision. If you or a loved one has been diagnosed with keratoconus, understanding how CXL works, who qualifies, and what to expect can help you make informed decisions about preserving long-term vision.
What is corneal cross-linking and how does it work?
Corneal cross-linking is a minimally invasive procedure that strengthens the cornea by increasing the number of chemical bonds (cross-links) between collagen fibers in the corneal stroma. The standard CXL technique combines riboflavin (vitamin B2) solution applied to the cornea with controlled ultraviolet-A (UV-A) light. Riboflavin absorbs the UV-A energy and creates reactive oxygen species that form new cross-links, stiffening the cornea and resisting further deformation.
There are two commonly discussed approaches:
- Epithelium-off (epi-off or “Dresden protocol”): The corneal epithelium is removed to allow effective riboflavin penetration. This is the most studied and widely accepted method for halting progression.
- Epithelium-on (transepithelial or epi-on): The epithelium is left intact to reduce discomfort and speed recovery, but penetration of riboflavin is less reliable and some studies show reduced efficacy compared with epi-off.
Who is a candidate for CXL?
CXL is intended for patients with progressive keratoconus — meaning measurable worsening over time. Indications commonly include:
- Documented increase in corneal steepness (keratometry) or irregular astigmatism on corneal topography/tomography
- Progressive decline in best-corrected visual acuity despite optimized contact lens or glasses correction
- Young age (teenagers and young adults are at higher risk of progression and are frequent candidates)
General considerations and limitations:
- Minimum corneal thickness: The standard epi-off protocol is typically performed when stromal thickness is at least ~400 microns after epithelium removal. Thinner corneas may be treated with modified techniques (contact-lens assisted CXL, hypoosmolar swelling) on a case-by-case basis.
- Active infection, severe scarring, pregnancy, and certain uncontrolled ocular surface diseases are relative contraindications.
- Because keratoconus progression is most common in younger patients, earlier treatment is often recommended when progression is documented.
What to expect during and after the procedure
Typical steps during a standard epithelium-off CXL:
- Topical anesthetic drops are applied for comfort.
- The central epithelium is gently removed.
- Riboflavin drops are instilled periodically for roughly 20–30 minutes until the stroma is adequately saturated.
- UV-A light is applied for a set time (standard protocol: 30 minutes at 3 mW/cm² delivering 5.4 J/cm²). Accelerated protocols use higher intensity over shorter times; your surgeon will choose the appropriate regimen.
- A bandage contact lens is placed and topical antibiotics and anti-inflammatory drops are prescribed.
Recovery and visual course:
- First 1–3 days: discomfort, foreign-body sensation, tearing, and light sensitivity are common while the epithelium heals.
- First 1–2 weeks: blurred vision often persists; the bandage contact lens is removed once epithelial healing is confirmed.
- Months: corneal remodeling occurs over 3–12 months; most eyes stabilize and many show flattening of the cone and improved functional vision over time.
Benefits, risks, and outcomes
Benefit: The primary, evidence-based benefit of CXL is halting or significantly slowing keratoconus progression. Many clinical studies show stabilization in the majority of treated eyes, and some patients experience modest flattening of the cornea and improved vision.
Risks and potential complications include:
- Delayed epithelial healing or persistent surface irregularity
- Corneal haze or scarring (usually mild and often improves with time)
- Infection (rare with proper technique and postoperative care)
- Endothelial cell damage if CXL is performed on corneas that are too thin
- Failure to halt progression in a small percentage of patients
Overall, when patients are properly selected and treated by experienced clinicians, CXL has a favorable safety profile and is the only treatment demonstrated to change the natural history of keratoconus.
Adjunct and alternative options: visual rehabilitation and ocular surface care
While CXL addresses progression, it does not directly correct the irregular astigmatism caused by keratoconus. Visual rehabilitation often requires specialty contact lenses—scleral lenses are a mainstay for many patients because they vault over the cornea, provide a regular optical surface, and are comfortable for irregular corneas. For advanced or refractory cases, intracorneal ring segments (Intacs) or corneal transplant surgery remain alternatives.
Ocular surface health is important before and after CXL. Dry eye or surface inflammation can impair healing and increase risks. Low-Level Light Therapy (LLLT) is an FDA-cleared adjunctive treatment we use for dry eye management; improving the tear film and eyelid inflammation with LLLT can optimize outcomes and comfort during recovery. Your eye care team will assess and manage dry eye, recommend temporary cessation of eye rubbing, and coordinate contact lens fitting once the cornea is fully healed.
Follow-up care and long-term monitoring
After CXL, regular follow-up with corneal topography or tomography is essential to confirm stabilization. Typical follow-up intervals include 1 day, 1 week, 1 month, 3 months, 6 months, and then annually or as advised. Repeat CXL is rarely needed but may be considered in cases of documented continued progression.
Because keratoconus can have a genetic component, family screening is often recommended for first-degree relatives. Early detection allows timely monitoring and, when necessary, intervention to preserve vision.
If you or a family member have been diagnosed with keratoconus or you are seeing changes in vision, evaluation for corneal cross-linking and a comprehensive management plan can make a meaningful difference. Our doctors specialize in keratoconus diagnosis, co-management for CXL, scleral lens fitting for visual rehabilitation, and dry eye treatments including LLLT. Schedule an appointment with Evolutionary Eye Care — serving Sugar Land, Webster, and Downtown Houston — to discuss whether CXL or another treatment pathway is right for you.